Sociedad Química y Minera de Chile S.A. (SQM) Earnings Call Transcript
August 19, 2026
Earnings Call Speaker Segments
Hello everyone, and welcome to SQM's conference call covering our Q2 2026 results. This session is being broadcast over the web and recorded. You can find our earnings release along with the related results presentation on our site, plus a hyperlink to the webcast there. Joining us on the line today are Mr. Ricardo Ramos, our Chief Executive Officer; Mr. Gerardo Illanes, Chief Financial Officer; Mr. Carlos Diaz, who heads Novandino as CEO; Mr. Pablo Altimiras, CEO of the iodine and Plant Nutrition division; and Mr. Mark Fones, CEO of the International Lithium division. We're also joined by colleagues from our commercial and business intelligence team: Mr. Felipe Smith, Commercial Vice President of Novandino; Mr. Joining us on this call are Pablo Hernandez, who serves as Vice President of Strategy and Development of Novandino; Mr. Juan Pablo Bellolio, our Commercial Vice President for Plant Nutrition & Specialty Products; Mr. Alvaro Araya, the CFO of the International Lithium Division; Mr. Andres Fontannaz, Commercial Vice President of the International Lithium Division; and Mr. Max Vial, Head of Studies of the International Lithium division. Before we get started, please note that any remarks made today regarding our business outlook, future economic performance, anticipated profitability, revenues, expenses and other financial items, along with expected cost synergies and growth in product or service lines, constitute forward-looking statements under U.S. federal securities laws. These statements are not historical facts and involve risks and uncertainties that could cause actual results to differ materially. We aren't committing to revise these remarks, unless the law demands it. If you'd like a full review of forward-looking statements, please look at our earnings press release and presentation; now I'll pass things along to our Chief Executive Officer, Mr. Ricardo Ramos.
Thanks. Good morning, everyone, and I appreciate your joining us today. It's a pleasure to share SQM's second quarter results, and those numbers show strong performance across our primary business segments. First, I want to point out a significant milestone reached by our lithium operations in Chile. In July, Novandino Litio — the joint venture we formed with Codelco — handed over the environmental and technical documentation for the Salar Futuro project to the authorities. Salar Futuro marks the following phase in reshaping what we do at the Salar de Atacama, assuming we receive the necessary approvals. Roughly $3 billion of investment spread across 7 years is envisioned under this project, and its purpose is to boost output while greatly lowering the environmental impact of our activities. I'd also like to call attention to what our operations gave back to Chile. Across the first half of this year, payments to the Chilean government from SQM and its subsidiaries totaled more than $1.6 billion, covering taxes, contributions to local governments, and payments to CORFO. Now, on the lithium market: we hit record quarterly sales volumes, moving over 84,000 metric tons of lithium carbonate equivalent from our Chilean operations via Novandino Litio as well as from Australia through Covalent Lithium. As we anticipated in our prior earnings report, lithium prices rose in the second quarter, backed by demand that came in stronger than expected. Our current projection is that worldwide lithium demand will surpass 2.1 million metric tons in 2026. We keep growing our production capabilities in Chile and Australia alike. On the Chilean side, we anticipate Novandino Litio will generate between 280,000 and 290,000 metric tons of lithium carbonate equivalent during this year, and will hold roughly 300,000 metric tons of production capacity by the following year. In Australia, alongside our partner Wesfarmers, we recently made public the expansion of the Mount Holland mine and concentrator. That expansion should double spodumene concentrate production capacity to about 350,000 metric tons annually, matching SQM's share of the project, with first production anticipated in 2030. These investments demonstrate our long-term perspective on the lithium market and our belief in the fundamentals underlying the energy transition. Switching to iodine, we once again posted solid results, aided by strong market demand and attractive pricing. We anticipate demand will stay strong. Our seawater pipeline is presently undergoing commissioning and will deliver added flexibility so we can optimize production and react to market conditions. Iodine is now being produced at all four of our operations, and we project total iodine production will hit approximately 15,500 metric tons this year. On specialty plant nutrition, we enjoyed another robust quarter, helped by increased sales prices and volumes. Our expectation remains that full year sales volumes will rise by roughly 10% versus 2025. Market conditions have gained from supply constraints in certain markets, and we anticipate that situation will steadily normalize as the year draws to a close. Last, we've refreshed our capital expenditure outlook — 2028 is now included — and we foresee total capital expenditures of approximately $3 billion across the 3-year '26-'28 period. The primary aim of this spending is to back upcoming expansion and boost how competitive our operations are by bringing production costs down. On the whole, the results we turned in across the first half of the year leave us encouraged, and our attention stays on carrying out our growth initiatives and building long-term value for shareholders. So with that, operator, I'll hand things over and we can move to the Q&A. Thank you.
I'll go through a few questions, taking them one at a time. Could we spend a moment on Q3? Looking at the lithium business in Q3, your guidance implies pricing roughly unchanged and volumes also appear roughly unchanged. Then on expenses, I wanted to ask, since costs came down significantly in Q2, should we anticipate that Q3 lithium earnings gross margin will land at approximately the same level as Q2?
Joel, Felipe here. Naturally, I'll speak to the Novandino piece. So yes, we truly did have an excellent second quarter. We're quite excited about the way the market is performing. As for Q3, to start with, when it comes to sales volume, we anticipate Q3 2026 staying strong, consistent with Q2, all right? And when it comes to price, I'd say the average price is derived from the indexes, since you're aware that all our contracts are tied to indices, and those indices are publicly available. On that basis, we think the Q3 price ought to be roughly aligned with the average we recorded during the first semester. That said, no one is able to forecast where the indices will head. The market is highly volatile right now, and predicting prices over a longer horizon remains tough.
Carlos Diaz here, Joel. On the point you raised about cost: what's mainly happened is that we've put in a lot of effort over the past 12 months, with an ongoing push on efficiency and improvement, and alongside that, economies of scale from our rising output have let us keep delivering cost gains. That said, for Q3 we're anticipating a cost much like what we saw in Q2. Looking ahead, though, in early '26 it ought to come in below where it was last year.
I'd like to inquire about price realizations when comparing Novandino with International Australia. Some of the math involving toll and similar items, I get that. However, consider Chile's premium — Novandino's average selling price is truly growing, meaning the discount, the premium on Novandino's average selling price, that premium is genuinely getting wider relative to international. In Q3, ought we to anticipate a catch-up? Even supposing Novandino's average selling price stays roughly flat in Q3, shouldn't international selling price be expected to catch up, rise, and the gap narrow?
Joel, Andres Fontannaz here, from lithium international. Our sales, well, the bulk of them rest on spodumene concentrate. To make a comparison, then, conversion costs must be added in, and the conversion yield has to be factored in as well. That, right there, is where the primary discrepancy lies. Ultimately, the thing of greatest importance is that we too are tracking the market — these shipments, they're discrete, since sales don't happen each month. At the moment of shipment, every one of these shipments tracks market conditions.
That's really the crux of what I'm asking, though. Based on our own figures, the average selling price for spodumene rose by $600 between Q1 and Q1 — I mean Q1 to Q2. From Q1 to Q2, spodumene's price per ton climbed $600, yet your average international selling price on an LCE equivalent basis hardly moved. That's the part I can't make sense of.
Right. Well, like we've said previously, the timing of shipments plays a role in what our prices look like. Once again, we don't have shipments every single month. And as I mentioned, over the next few quarters, that will come through more clearly in how we report our prices.
I'll squeeze in one final question, if I may. So for the whole year, you lifted your lithium demand projections by 200,000 tons. My guess is you'll respond that this comes entirely from the demand side, driven by energy storage. Where will that additional 200,000 tons of supply originate? Would that be restarts in Australia? Would that be Africa? Would that be lepidolite in China? Where will the additional 200,000 tons of supply come from during this year to satisfy rising demand?
Joel, it's Pablo Hernandez here. Naturally, these are only our estimates; therefore, we aren't able to fully forecast what is truly taking place in the market. Still, we think there is a certain rise in supply, mostly originating from China, from spodumene as well as brine, yet additionally a few ramp-up projects in Africa and Argentina; and naturally, as you've been told, given the present pricing situation, there are a few restarts in Australia too, also arriving in the market.
Can you hear me?
Two things I'd like to ask. The first one is about the lithium market still, correct? From what I understand, you're increasing output at Novandino more quickly than was anticipated back when the agreement was signed. So I'm curious whether you might bring us up to date on — and you brought up roughly 300,000 tons for next year. Yet past that, and once the new concession takes effect, what level of production could realistically be achieved, particularly with Salar Futuro operating, in terms of yearly output; that's my first one. Then my second one concerns the iodine market, correct? Volumes and prices both made it a fairly strong quarter. And you noted there's been some kind of sales deceleration, I think, since additional supply is arriving. Could you say a bit more about where that supply originating from third parties is entering the market and what it might mean for pricing during the second half? Thanks.
Isabella, it's Carlos Diaz here once more. So this year, we anticipate, as our CEO previously stated, that we'll make somewhere around 280,000 to 290,000 metric tons. Then going forward, expansion will at first be modest while we keep cutting back on brine extraction. To be specific, for next year we're looking at output near 300,000. As for the year after, we're still evaluating various initiatives so we can maintain and slightly raise production. However, you must keep in mind that we've been lowering brine extraction. So that's a process we aren't prepared to discuss just yet. So likely on the next conference call we'll be able to share that with you.
Pablo Altimiras here. So, in response to what you asked about iodine and the additional supply — once again, these are our own projections, though we think the bulk of that supply would likely come from projects located in Chile. There's one specific new project we're watching; it's a <<inaudible>> project in terms of how much product will hit the market — honestly, we don't know for certain, but our expectation is that they'll bring more product. That's why we think our sales volume for this year is going to be comparable to what we saw last year. Naturally, if something changes on the supply side, we might potentially record higher sales ourselves, but it all hinges on supply and demand.
Just one last point regarding iodine. If you could, would you be able to put a bit of a number on what this new project in Chile represents when it comes to volumes, and also, is there any meaningful impact on supply and demand, and in the end on prices?
The key thing to keep in mind is that demand has looked solid. For this year, our projection is for growth of roughly 3%, so our expectation is that the fresh capacity entering the market will offset that expansion, though we don't anticipate anything beyond that.
I have a few questions. To start, could you break down the anticipated 300,000-ton production capacity increase for 2027? Specifically, how much of that will come from Chile, since you're converting the hydroxide plant? And what portion will come from tolling contracts? That's my first question, and I have some follow-ups after that.
Emerson, this is Carlos Diaz. To begin with, everything we produce originates at the Salar de Atacama, through 2 distinct routes. The first is lithium chloride, which gets refined in Chile, and the second is lithium sulfate, refined in China. So, as I mentioned earlier, for this year we're looking at 280,000 to 290,000, and 300,000 for next year. Out of that, our current estimate is that 80,000 will come from lithium sulfate, while the remaining 220,000 will come from our Antofagasta chemical plant. Apologies — were you asking about hydroxide production?
Carbonate.
About carbonate — well, of the total, we aren't seeing beyond 20,000 or 30,000 of those, which means hydroxide would account for 10% of that production, and the rest, clearly, would be carbonate.
All right, and very briefly on Mount Holland. You recently gave the green light to the expansion — on the mining side, the concentrator — so I'm just curious whether there might be an expansion at the refinery as well. Are you perhaps intending to move on that only once those expansions wrap up? And how are you viewing the split between hydroxide and spodumene sales as we head into 2027 and beyond, please.
Mark Fones speaking. Appreciate the question. On that — to begin with, the choice to expand Mount Holland is something we're quite proud of. Starting with the mining concentrator. As for the refinery, that call is still one we haven't closed on. No conclusion or decision has been reached on it as of yet. Covalent and our partner, farmers, will keep studying it. It will also hinge on getting our ramp-up all the way complete by the second half of next year, from that point onward. And when it comes to the mix for next year in sales and production, we anticipate that lithium hydroxide output next year will exceed this year's, certainly, tracking that same ramp-up curve. So our direct spodumene concentrate sales ought to come in likely below this year's level.
To start, I want to ask something further about sulfate output, particularly the tolling arrangements over in China. That output really caught me off guard. Honestly, I didn't imagine you folks could scale that tolling up so quickly and locate so much available capacity in what was a fairly brief window. So what I'd like to know concerns those tolling agreements. I'm just trying to get a handle on their duration. And do you foresee any danger that, across the coming several years, you'd need to hand some of it off or bring in different partners for that tolling, perhaps at other pricing levels, should those fees turn out to be set and forecastable? I'm just trying to grasp the operational exposure involved in running, if I have it right, roughly 50,000 tons of sulfate tolling alongside those third parties. Then my second question follows up on Mount Holland, given that the expectation points to our first output arriving in 2030. That strikes me as a rather drawn-out stretch of time, particularly since this is a brownfield. I'm simply curious what the next major milestones are there that you believe ought to be leveraged to grow output capacity, or what the chief obstacles are to getting that capacity up and running.
Carlos Diaz here. On the subject of lithium sulfate output, yes, we've been pushing production up quite aggressively over the past 3 or 4 years. As we stated previously, we anticipate this year — we anticipate generating, next year, somewhere between 80,000 and 90,000 on an LCE equivalent basis. Above all, let me note that we operate our very own facility in China, the lithium plant where we turn out approximately 24,000 to 25,000; we're in the middle of expanding; we look to hit 30,000, in that vicinity. As for the remainder, we handle the tolling through a separate supplier whose contract we keep confidential, yet we're quite pleased with the arrangement we hold, and we anticipate carrying on with them through the year ahead.
Mark Fones here. About the Mount Holland timeline — you're correct that we expect the first product in the first half of 2030. The schedule mirrors how a project of this size normally unfolds, and we're setting things up so the projects come in with risk reduced rather than accelerated. You should also keep in mind that this is a significant brownfield expansion, not a minor one; we're doubling capacity at a site where we already run operations. If I were to offer some milestones, as you requested, I'd say the next important one concerns beginning construction of the facility itself, which ought to take place in the middle of next year. Building a facility like this one runs between 18 and 24 months. Before that, naturally, we have to buy long-lead items and get earthworks and earth movement ready. Once those 18 to 24 months of construction are done, a commissioning period follows, running into 2029, so that we reach first product at the start of 2030. That's the broad picture and the key milestones within it. As for whether there's any chance to shorten this schedule — yes, such chances exist. Covalent and our technical teams are actively advising on and analyzing them, and we'll keep pushing it forward. But do bear in mind that while this brownfield naturally offers meaningful opportunities, given that we're operating at an existing site, it also brings greater levels of difficulty, and we must always mine safely.
Could we revisit what you said regarding third-quarter sales matching the second quarter? How should we view that for the fourth quarter, since normally, based on seasonality, I believe the fourth quarter is your strongest? Are you also anticipating the fourth quarter to reach the high 70s, perhaps around 80 kilotons apiece? Or do you think a robust third quarter will be followed by a weaker fourth quarter?
Corrine, Felipe here — the fourth quarter is still a long way off. So I'll attempt to discuss what lies ahead, the distant future, though I can only wish that we might at least match the volume from the second and third quarters, because, as I mentioned earlier, for the third quarter we anticipate a volume comparable to the second quarter. Thus, for the fourth quarter I'm expecting a minimum, yet hoping it might exceed that; however, once more, my boss is giving me a look like, what are you up to? Still, that's just my own personal hope, all right?
So that ought to put you folks at 315 to 320 kilotons, and that's way beyond the guidance you gave, isn't it?
Correct. If you're asking just about the Novandino piece, what I'll say is I expect Novandino to come in above 280, and after that my international colleagues can weigh in — maybe Andres, over to you.
This is Andres, and for the entire year, we're looking at sales in the range of 27,000 to 30,000 tons LCE.
All right, that's useful. Now, perhaps a broader question, since I believe some investors have begun thinking a bit more about the long run. Could you discuss what takes place beyond 2030, into 2031? We understand Codelco will likely be far more in charge than your company. Still, if you could give us a big-picture perspective and put it into context for us, plus how we ought to consider strategic choices and CapEx and so forth, that would be useful. Thanks.
This is Ricardo Ramos, yes, as Felipe mentioned, the fourth quarter is genuinely long term. It is truly quite distant. For 2031, making forecasts about what will occur is simply somewhat harder; yet once more, I believe we are currently doing very well at Novandino. I believe the arrangement with Codelco has actually exceeded expectations when it comes to coordinating and collaborating at the Board level, with cooperation between the two companies; that's the reason we feel quite optimistic about it. We already stated in the press release that we are beginning the submission. We submitted it during July for the Salar Futuro. We're engaged in engineering, in all aspects, so as to be prepared for the investment. That's why I expect that in 2031, we would be midway through the Salar Futuro investment. We believe it will be an excellent project. We are truly dedicated alongside Codelco to achieve this. I believe everything is captured within our long-term projections, the entire investment of the work we intend to carry out and what Carlos is doing presently with his team is attempting to build a very solid expectation regarding the volumes, sales volumes for the future. And I believe we will share with all of you during the next conference call our initial perspective about what we anticipate for the following year, and we will keep maintaining a long-term outlook. However, we are working extremely hard and have very solid agreements thus far, and Codelco is an excellent partner.
Only 2 things from me. First, I believe there's some confusion among investors regarding your recent filing about $3 billion being spent at Salar Futuro, and a few people are concluding that every dollar of it goes toward raising capacity by 30,000 tons. That would imply CapEx of $100,000 per ton. I think that's incorrect. Could you break apart the $3 billion outlay and the 30,000 — pardon me, 30,000 ton capacity increase?
Ben, it's crucial to keep in mind that Salar Futuro isn't merely about adding capacity; it's also a technology change. What that means is — as you're aware — we're providing a really strong technology when it comes to cost, when it comes to production, when it comes to environmental footprint. So that's the reason you need to look at the Salar Futuro project in its entirety, in the sense of a fresh start for Salar de Atacama over the next 60 years of operation. That's precisely our 30 years of operation that we have, that's the entire concept. And naturally, we anticipate greater production. We're working on that, and it will hinge on the deals and hinge on how good the solutions are that we bring into the process. But — and we'll share our best estimate within the next 2 years, yet the entire Salar Futuro project isn't simply a notion for boosting production capacity. It goes far beyond that, in the sense of a revamping, of having a new Salar de Atacama for the future.
That's clear. My follow-up concerns the lithium sector. From what I gather, output for battery storage has reached roughly 1 terawatt hour, yet deployments amount to only around 50% of that figure. So I want to ask: is a significant stockpile accumulating in battery storage, potentially leading us toward a short-term surplus during the coming 12 to 18 months, which might limit how much lithium demand can grow? Or does this simply reflect the usual pattern, where the delay means it takes 6 months to a year to close the gap? I'm just attempting to figure out whether this situation is unusual or whether such a growth rate can continue?
This is Pablo Hernandez; so I — to start with, I share your perspective regarding the market. We have indeed witnessed battery shipments for BESS substantially exceeding the actual deployment of those units. Consequently, a certain disparity exists that we continue to track. Our assessment is that the majority of this disparity stems from bigger projects currently underway, and bigger projects inherently involve extended timelines for execution along with holdups tied to approvals and similar matters; thus a delay of that nature is expected. Naturally, though, I also suspect some sales have been pulled ahead from 2027 owing to tax rebates eliminated on China's export side. Taking everything together, my longer-term outlook is that in the years ahead, we could observe a deceleration in how quickly BESS battery deployment expands. Apologies, Ben, allow me to wrap up. Even so, BSS will certainly stay a highly significant and robust source of demand going forward.
That brings our question-and-answer portion and today's conference to a close, everyone. We appreciate all of you for joining us, and at this point you're free to hang up.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Sociedad Química y Minera de Chile S.A. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Sociedad Química y Minera de Chile S.A. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.